Roswell Park Comprehensive Cancer Center
P

Minimal Residual Disease (MRD) Testing in Multiple Myeloma. How and When to Do It?

By Roswell Park Comprehensive Cancer Center FEATURING Philip McCarthy
11/2018
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
City of Hope

How the Experts Treat Hematologic Malignancies

Thu, Mar 21, 2019
Indy Hematology Review

16th Annual Indy Hematology Review

Sat, Mar 9, 2019
17:57
Parameswaran Hari

Delivering the Best Initial Treatment for Myeloma: Induction Therapy and...

08:14
2018 Pan Pacific Lymphoma Conference

Evolution of Myeloma Induction Regimens

Feat. S. Holstein
15:46
Society of Hematologic Oncology Sixth Annual Meeting

Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...

Feat. S. Lonial
09:49
Nina Shah

Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maint...

15:36
Society of Hematologic Oncology Sixth Annual Meeting

How Does Genetics and MRD Impact Myeloma Treatment Or Doesn’t It?

Feat. A. Nooka
15:01
Krina Patel

Clinical Trials in Myeloma in 2018

13:25
Shaji Kumar

Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma

10:29
Society of Hematologic Oncology Sixth Annual Meeting

Next Questions in Myeloma: Biology, Smoldering Myeloma, High-risk, MRD, ...

Feat. S. Jagannath
19:40
Peter Voorhees

Approach to the Patient with Refractory & Multiple Relapsed Multiple Mye...

12:31
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson
15:10
Ajay Nooka

Early Relapse: Choosing Among Different Second Line Regimens in Myeloma

15:30
Parameswaran Hari

Refractory and Relapsing Myeloma - When to Treat and Options Available

12:43
Bart Barlogie

Clinical Manifestations & Diagnostic Work Up of Myeloma

17:46
Dana-Farber Cancer Institute

Relapse Refractory Myeloma and Novel Treatments

Feat. N. Raje
06:22
Parameswaran Hari

Treating Refractory & Relapsing Myeloma: Current Trends and Recommendati...

09:00
Maria-Victoria Mateos

FDA Approves Once-Weekly Carfilzomib Regimen for Myeloma

16:58
Nina Shah

The Future of CAR T Therapies in Myeloma in 2018

14:42
Society of Hematologic Oncology Sixth Annual Meeting

What Will The Future Hold for Myeloma Treatment CARTs vs BiTES?

Feat. R. Orlowski
11:50
C. Ola Landgren

Aiming for Minimal Residual Disease Negative Status in all Myeloma Patients